[Follow-up in patients with testicular germ cell tumors-an update].

IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY
Urologie Pub Date : 2025-10-01 Epub Date: 2025-09-20 DOI:10.1007/s00120-025-02675-6
Klaus-Peter Dieckmann, Markus Angerer, Felix Bremmer, Armin Soave
{"title":"[Follow-up in patients with testicular germ cell tumors-an update].","authors":"Klaus-Peter Dieckmann, Markus Angerer, Felix Bremmer, Armin Soave","doi":"10.1007/s00120-025-02675-6","DOIUrl":null,"url":null,"abstract":"<p><p>Systematic follow-up (FU) examinations in patients with testicular germ cell tumors (GCTs) came into practice in the 1980s. The goal is to detect recurrent disease as early as possible to facilitate successful treatment. Cross-sectional imaging and tumor marker measurements (AFP, bHCG) represent the mainstay of FU examinations. Due to the biological and clinical diversity of GCTs, there is no uniform general pattern of examinations that would suit all GCT patients. Therefore, FU should be performed in a risk-adapted way; the rationale of which is to tailor examinations to the extent needed, while keeping examinations as short as possible. In the entire population of testicular GCTs, there are around 20 different risk categories that are characterized by histology, clinical stage, and antecedent treatment and that differ from each other with respect to frequency of relapses (2-50%), time interval to relapse, and topography of recurrent disease. In terms of clinical practice, three risk groups should be employed: (1) seminoma all stages, (2) nonseminoma clinical stage 1, and (3) nonseminoma all other clinical stages. The FU examinations specifically required in these categories are listed in three roster tables, accordingly. The following items are at variance with the German S3 guidelines from 2019: (a) the number of risk groups is reduced to three (instead of 4) and the groups are newly defined, (b) cross-sectional imaging with computed tomography (CT) is replaced by magnetic resonance imaging (MRI) for reasons of radiation protection, (c) abdominal sonography is replaced by MRI for reasons of superior diagnostic accuracy, (d) no more chest X‑ray in FU of seminoma patients, and (e) lactate dehydrogenase (LDH) no longer a marker for testing in FU. Another goal of FU is the early detection of second diseases ensuing from treatment of GCT such as hypogonadism, metabolic syndrome, cardiovascular diseases, and second malignancies. Therefore, FU should be continued beyond the 5 year threshold with annual visits.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1024-1036"},"PeriodicalIF":0.4000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00120-025-02675-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Systematic follow-up (FU) examinations in patients with testicular germ cell tumors (GCTs) came into practice in the 1980s. The goal is to detect recurrent disease as early as possible to facilitate successful treatment. Cross-sectional imaging and tumor marker measurements (AFP, bHCG) represent the mainstay of FU examinations. Due to the biological and clinical diversity of GCTs, there is no uniform general pattern of examinations that would suit all GCT patients. Therefore, FU should be performed in a risk-adapted way; the rationale of which is to tailor examinations to the extent needed, while keeping examinations as short as possible. In the entire population of testicular GCTs, there are around 20 different risk categories that are characterized by histology, clinical stage, and antecedent treatment and that differ from each other with respect to frequency of relapses (2-50%), time interval to relapse, and topography of recurrent disease. In terms of clinical practice, three risk groups should be employed: (1) seminoma all stages, (2) nonseminoma clinical stage 1, and (3) nonseminoma all other clinical stages. The FU examinations specifically required in these categories are listed in three roster tables, accordingly. The following items are at variance with the German S3 guidelines from 2019: (a) the number of risk groups is reduced to three (instead of 4) and the groups are newly defined, (b) cross-sectional imaging with computed tomography (CT) is replaced by magnetic resonance imaging (MRI) for reasons of radiation protection, (c) abdominal sonography is replaced by MRI for reasons of superior diagnostic accuracy, (d) no more chest X‑ray in FU of seminoma patients, and (e) lactate dehydrogenase (LDH) no longer a marker for testing in FU. Another goal of FU is the early detection of second diseases ensuing from treatment of GCT such as hypogonadism, metabolic syndrome, cardiovascular diseases, and second malignancies. Therefore, FU should be continued beyond the 5 year threshold with annual visits.

[睾丸生殖细胞肿瘤患者的随访研究进展]。
系统随访(FU)检查睾丸生殖细胞肿瘤(gct)患者在20世纪80年代开始实施。目标是尽早发现复发性疾病,以促进成功治疗。横断成像和肿瘤标志物测量(AFP, bHCG)是FU检查的主要内容。由于GCT的生物学和临床多样性,没有统一的通用检查模式适用于所有GCT患者。因此,FU应以适应风险的方式进行;其基本原理是根据需要调整考试,同时尽可能缩短考试时间。在整个睾丸gct人群中,大约有20种不同的风险类别,这些类别以组织学,临床分期和先前治疗为特征,并且在复发频率(2-50%),复发时间间隔和复发疾病的地形方面彼此不同。在临床实践中,应采用三个风险组:(1)精原细胞瘤所有阶段,(2)非精原细胞瘤临床1期,(3)非精原细胞瘤所有其他临床阶段。因此,这些类别特别需要的综合考试列在三个花名册表中。以下项目与2019年起的德国S3指南存在差异:(a)危险组的数量减少到3个(而不是4个)并重新定义组,(b)出于辐射防护的原因,计算机断层扫描(CT)被磁共振成像(MRI)取代,(c)由于诊断准确性更高,腹部超声检查被MRI取代,(d)精原细胞瘤患者FU不再使用胸部X线检查,(e)乳酸脱氢酶(LDH)不再是FU检测的标志物。FU的另一个目标是早期发现GCT治疗后的二次疾病,如性腺功能减退、代谢综合征、心血管疾病和二次恶性肿瘤。因此,FU应继续超过5年的阈值,每年就诊。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urologie
Urologie UROLOGY & NEPHROLOGY-
CiteScore
1.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信